| ANEBULO PHARMACEUTICALS |
| USA |
| Gesundheit |
| US0345691036 / A3CM1D |
| 214 (Frankfurt) / ANEB (NASDAQ) |
| FRA:214, ETR:214, 214:GR, NASDAQ:ANEB |
| - |
| https://www.anebulo.com/ |
|
Anebulo Pharmaceuticals Inc. is a biopharmaceutica..
>Volltext.. |
| 94.01 Mio. EUR |
| 84.11 Mio. EUR |
| - |
| -7.99 Mio. EUR |
| -7.35 Mio. EUR |
| -0.23 EUR |
| - |
| 10.08 Mio. EUR |
| -5.5 Mio. EUR |
| 23.84 |
| - |
| 5.93% |
| - |
| - |
| - |
| - |
| ANEBULO |
| 03.11.25 |
|